Are there any special considerations you take with ESA use in hospitalized patients with ESKD who undergo stem cell transplantation?  

There really are no guidelines for the use of ESAs in this population. Generally, these patients receive PRBC support for severe and/or symptomatic anemia. We do not prescribe ESAs int this setting because we suspect that the response will be suboptimal given the inflammatory state of these patients...